NRIX

Nurix Therapeutics, Inc.

• TipRanks·1d ago

  Nurix Therapeutics management to meet with Piper Sandler

• Seeking Alpha·1d ago

  Oppenheimer's top 50 small- and mid-cap Buy list

• Seeking Alpha·10/19 11:05

  Cathie Wood's weekly recap: adds to CoreWeave, Meta, Recursion; cuts Personalis, Toast

• TipRanks·10/17 13:01

  Cue, Nurix, Flowers, MarketAxess, Borr: Insider Shake-Up

• Dow Jones·10/16 20:35

  Nurix Therapeutics Price Target Raised to $36.00/Share From $34.00 by HC Wainwright & Co.

• Dow Jones·10/16 20:35

  Nurix Therapeutics Is Maintained at Buy by HC Wainwright & Co.

• Benzinga·10/16 12:25

  SpaceX To Rally Around 85%? Here Are 10 Top Analyst Forecasts For Friday

• TipRanks·10/16 10:20

  Nurix Therapeutics price target raised to $36 from $34 at H.C. Wainwright

• Benzinga·10/16 10:13

  HC Wainwright & Co. Maintains Buy on Nurix Therapeutics, Raises Price Target to $36

• TipRanks·10/15 12:40

  Analysts Offer Insights on Healthcare Companies: Janux Therapeutics Inc (JANX), Nurix Therapeutics (NRIX) and Sanofi (OtherSNYNF)

• The Wall Street Journal·10/15 09:30

  Big Pharma Is Pouring Billions Into a New Class of 'Protein Degrader' Drugs

• TipRanks·10/15 02:00

  Major Insider Move at Nurix Therapeutics Sparks Investor Buzz

• Seeking Alpha·10/14 10:46

  Nurix: Maintaining 'Strong Buy' Updated Bexobrutideg Data CLL/SLL And Multiple Advancement Pathways

• TipRanks·10/14 06:00

  Nurix Therapeutics’ High-Stakes Reliance on Roche: Cost Burdens, Control Risks and Uncertain Returns for Lead Drug Bexobrutideg

• Dow Jones·10/13 15:04

  Nurix Therapeutics Price Target Cut to $35.00/Share From $36.00 by RBC Capital